Please login to the form below

Not currently logged in
Email:
Password:

Open Health adds pH Associates to its roster

UK real world data specialist will bolster Open's market access offering

Open Health has joined forces with pH Associates in a move the London-based communications group said would bolster its existing market access offering.

pH is one of the leading 'real world data' specialists in the UK and its addition to Open Health's ranks will see it line up alongside the group's Harvey Walsh and Succinct Market Access practices.

Sandy Royden, founding partner, Open Health:"The pH Associates brand is synonymous with excellence and leadership in the real world data and market access arena, and we are delighted to have them on board. We see many synergies across both our current market access practices, but also our wider range of services.”

The pH leadership team of Kate Peperell and Lesley Howell will form a new executive board alongside Open Health's David Rowley, Sandy Royden and Roger Selman.

Peperell, joint managing director of pH Associates, said:“We are very excited to be joining the Open Health family. There has been a paradigm shift in the acceptance and demand for data throughout the product lifecycle.

“The NHS need data converting to insight and also the practical tools to help drive change. The partnership with Open will allow us to continue to meet the ever increasing demand for data and also bring tremendous value to our clients through the wider market access offering.”

Marlow-based pH was founded in 1999 and its current pharmaceutical clients include Abbott, Janssen Cilag, Novartis and Sanofi. In addition, pH also works with NHS and academic clients, including a number of Medical Royal Colleges.

The current senior management team and structure of pH will remain unchanged and there will be no changes to the existing services the company offers. Also, all contracts will remain in place

17th October 2012

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...
International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...

Infographics